Silent myocardial ischemia and hormonal contraception in young women with metabolic syndrome

DOI: https://doi.org/10.29296/25877305-2019-08-13
Issue: 
8
Year: 
2019

M. Khabibulina, Candidate of Medical Sciences Ural State Medical University, Yekaterinburg

The frequency and severity of silent myocardial ischemia (SMI) were established in late reproductive-aged women with metabolically healthy obesity and various estradiol level; the effect of estrogen-containing contraceptives on the frequency and severity of manifestations of SMI was evaluated.
Keywords: 
cardiology
hormonal contraception
silent myocardial ischemia
metabolically healthy obesity
late reproductive age

References: 
  1. Glezer M.G. Stabil'naja stenokardija: posobie dlja vrachej obschej praktiki. Izd. 2-e, dop. i ispr. / M.: Medikom, 2012; 125 s. [Gleizer M.G. Stabil’naya stenokardiya: posobie dlya vrachei obshchei praktiki / M.: Medikom, 2012; p. 125 (in Russ.)].
  2. Shimanovskij N.L. Kompleksnoe vlijanie zhenskih polovyh steroidnyh gormonov na serdechno-sosudistuju sistemu: pol'za i risk // Mezhdunar. med. zhurn. – 2007; 3: 51–5 [Shimanovsky N.L. Complex influence of female sex steroid hormones on the cardiovascular system: benefit and harm // International medical journal. – 2007; 3: 51–5 (in Russ.)].
  3. Habibulina M.M. Vyjavlenie bezbolevoj ishemii miokarda na ambulatornom etape u zhenschin s arterial'noj gipertenziej i kardialgiej v period premenopauzy // Ros. kardiol. zhurn. – 2011; 16 (6): 14–8 [Khabibulina M.M. Ambulatory diagnostics of painless myocardial ischemia in premenopausal women with arterial hypertension and cardialgia // Russian Journal of Cardiology. – 2011; 16 (6): 14–8 (in Russ.)].
  4. Habibulina M.M. Mezhgennye vzaimodejstvija v formirovanii u zhenschin bezbolevoj ishemii miokarda // Vrach. – 2015; 9: 44–6 [Khabibulina M. Intergenic interactions in the development of silent myocardial ischemia // Vrach. – 2015; 9: 44–6 (in Russ.)].
  5. Habibulina M.M. Kardiovaskuljarnyj risk pri estrogenodefitsite v doklimaktericheskih periodah. Rukovodstvo dlja vrachej / Ekaterinburg, 2014; 143 s. [Khabibulina M.M. Kardiovaskulyarnyi risk pri androgenodefitsite v doklimaktericheskikh periodakh. Rukovodstvo dlya vrachei / Ekaterinburg, 2014; p. 143 (in Russ.)].
  6. Smetnik V.P. Lechenie klimaktericheskih rasstrojstv // Med. sovet. – 2007; 4: 38–44 [Smetnik V.P. Lechenie klimaktericheskikh rasstroistv // Med. sovet. – 2007; 4: 38–44 (in Russ.)].
  7. Habibulina M.M. Izmenenie sostojanija sosudistogo rusla u molodyh zhenschin s estrogenodefitsitom, dislipidemiej i arterial'noj gipertenziej pod vlijaniem mertenila // Farmateka. – 2014; 6 (279): 12–8 [Khabibulina M.M. Izmenenie sostoyaniya sosudistogo rusla u molodykh zhenshchin s estrogenodefitsitom, dislipidemiei i arterial’noi gipertenziei pod vliyaniem mertenila // Pharmateca. – 2014; 6 (279): 12–8 (in Russ.)].
  8. Azarenkova T.A. Rol' zamestitel'noj gormonal'noj terapii v modifikatsii faktorov riska serdechno-sosudistyh zabolevanij u zhenschin s rannim estrogenodefitsitom. Avtoref. dis. … kand. med. nauk. Cheljabinsk, 2011; 22 s. [Azarenkova T.A. Rol’ zamestitel’noi gormonal’noi terapii v modifikatsii faktorov riska serdechno-sosudistykh zabolevanii u zhenshchin s rannim estragenodefitsitom. Avtoref. dis. … cand. med. nauk. Chelyabinsk, 2011; p. 22 (in Russ.)].
  9. Habibulina M.M., Dmitriev A.N. Sposob optimizatsii lechenija zhenschin kardiotropnoj terapiej i zamestitel'noj gormonal'noj terapiej pri estrogenodefitsite s arterial'noj gipertenziej v pozdnem reproduktivnom periode. Patent na izobretenie RUS 2648470 03.03.2016 [Khabibulina M.M., Dmitriev A.N. Sposob optimizatsii lecheniya zhenshchin kardiotopnoi terapiei i kzamestitel’noi gormonal’noi terapiei pri estrogenodefitsite s arterial’noi gipertenziei v pozdnem reproduktivnom periode. Patent na izobretenie RUS 2648470 03.03.2016. (in Russ.)].
  10. Ford E., Capewell S. Proportion of the decline in cardiovascular mortality disease due to prevention versus treatment: public health versus clinical care // Ann. Rev. Public Health. – 2011; 32: 5–22. https://doi.org/10.1146/annurev-publhealth-031210-101211.
  11. Habibulina M.M. Otsenka vlijanija dlitel'noj terapii preparatami ekvator (amlodipin i lizinopril) i predizin (trimetazidin) na remodelirovanie serdtsa, bezbolevuju ishemiju miokarda u zhenschin s estrogenodefitsitom i arterial'noj gipertenziej v premenopauze // Evrazijskij kardiol. zhurn. – 2014; 4: 54–60 [Habibulina M.M. Influence evaluation of long-term therapy with ekvator® and predisin® on morphofunctional rates and painless myocardial ischemia in premenopausal women with hypoestrogenemia and hypertension // Eurasian Heart Journal. – 2014; 4: 54–60 (in Russ.)].
  12. Robertson L., Aneni E., Maziak W. et al. Metabolically healthy obese phenotype & its association with clinical/subclinical cardiovascular disease and all-cause mortality – a systematic review // BMC Public Health. – 2014; 14 (1): 14. https://doi.org/10.1186/1471-2458-14-14.
  13. Habibulina M.M. Terapija u zhenschin s arterial'noj gipertenziej i estrogenodefitsitom v pozdnem fertil'nom periode // Vrach. – 2016; 4: 45–9 [Khabibulina M. Therapy in women with hypertension and estrogen deficiency in the late fertile period // Vrach. – 2016; 4: 45–9 (in Russ.)].
  14. Habibulina M.M. Vlijanie trojnoj gipotenzivnoj terapii na remodelirovanie serdtsa, bezbolevuju ishemiju miokarda pri arterial'noj gipertenzii s estrogenodefitsitom v premenopauze // Vrach. – 2018; 29 (10): 32–6 [Khabibulina M. Impact of triple antihypertensive therapy on cardiac remodeling, silent myocardial ischemia in hypertension in premenopausal women with estrogen deficiency // Vrach. – 2018; 29 (10): 32–6 (in Russ)]. https://doi.org/10.29296/25877305-2019-10-09.
  15. Christgau S., Tanko L., Cloos P. et al. Suppression of elevated cartilage turnover in postmenopausal women and in ovariectomized rats by estrogen and a selective estrogen-receptor modulator (SERM) // Menopause. – 2004; 11 (5): 508–18. DOI: 10.1097 / 01.WCB.0000121484.18437.98.
  16. Habibulina M.M. Gemodinamicheskie pokazateli u zhenschin s gipoestrogenemiej pri metabolicheski zdorovom ozhirenii // Vrach. – 2018; 29 (1): 34–7 [Khabibulina M. Hemodynamic parameters in women with hypoestrogenemia with metabolically healthy obesity // Vrach. – 2018; 29 (1): 34–7 (in Russ.)]. DOI: 10.29296/25877305-2018-01-09.
  17. Ioseliani D.G. Porazhenie venechnyh arterij i klinicheskoe techenie IBS u zhenschin reproduktivnogo vozrasta // Aktual'nye voprosy kardiologii. – 2006; 3: 391–410 [Ioseliani D.G. Porazhenie venechnykh arterii i klinicheskoe techenie IBS u zhenshchin reproduktivnogo vozrasta // Aktual’nye voprosy kardiologii. – 2006; 3: 391–410 (in Russ.)].